Springer Health+ IME
@SpringerIME
Springer Health+ IME, providing independent medical education in Neurology, Diabetes, Oncology, Rare Diseases, Endocrinology, and Paediatrics.
Joined March 2016
2.8K Following 19.8K Followers
Breaking from EASL 2026: Observational data show IBAT inhibitor promise for pruritus in late-onset PFIC and ICP.
